Cargando…
Mitochondrial protection by the mixed muscarinic/σ(1) ligand ANAVEX2-73, a tetrahydrofuran derivative, in Aβ(25–35) peptide-injected mice, a nontransgenic Alzheimer’s disease model
Alzheimer’s disease (AD), the most prevalent dementia in the elderly, is characterized by progressive synaptic and neuronal loss. Mitochondrial dysfunctions have been consistently reported as an early event in AD and appear before Aβ deposition and memory decline. In order to define a new neuroprote...
Autores principales: | Lahmy, Valentine, Long, Romain, Morin, Didier, Villard, Vanessa, Maurice, Tangui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4299448/ https://www.ncbi.nlm.nih.gov/pubmed/25653589 http://dx.doi.org/10.3389/fncel.2014.00463 |
Ejemplares similares
-
Nontransgenic models of breast cancer
por: H Heppner, Gloria, et al.
Publicado: (2000) -
A precision medicine framework using artificial intelligence for the identification and confirmation of genomic biomarkers of response to an Alzheimer's disease therapy: Analysis of the blarcamesine (ANAVEX2‐73) Phase 2a clinical study
por: Hampel, Harald, et al.
Publicado: (2020) -
Low‐gluten, nontransgenic wheat engineered with CRISPR/Cas9
por: Sánchez‐León, Susana, et al.
Publicado: (2017) -
Dataset on nicotine-free, nontransgenic tobacco (Nicotiana tabacuml.) edited by CRISPR-Cas9
por: Schachtsiek, Julia, et al.
Publicado: (2019) -
Nicotine‐free, nontransgenic tobacco (Nicotiana tabacum
l.) edited by CRISPR‐Cas9
por: Schachtsiek, Julia, et al.
Publicado: (2019)